MXCT Annual EBITDA
-$44.13 M
-$19.46 M-78.92%
31 December 2023
Summary:
As of January 23, 2025, MXCT annual earnings before interest, taxes, depreciation & amortization is -$44.13 million, with the most recent change of -$19.46 million (-78.92%) on December 31, 2023. During the last 3 years, it has fallen by -$34.18 million (-343.81%). MXCT annual EBITDA is now -6711.98% below its all-time high of -$647.80 thousand, reached on December 31, 2015.MXCT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MXCT Quarterly EBITDA
-$12.99 M
-$2.10 M-19.29%
30 September 2024
Summary:
As of January 23, 2025, MXCT quarterly earnings before interest, taxes, depreciation & amortization is -$12.99 million, with the most recent change of -$2.10 million (-19.29%) on September 30, 2024. Over the past year, it has dropped by -$116.00 thousand (-0.90%). MXCT quarterly EBITDA is now -541.21% below its all-time high of -$2.03 million, reached on September 30, 2021.MXCT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MXCT TTM EBITDA
-$42.03 M
-$116.00 K-0.28%
30 September 2024
Summary:
As of January 23, 2025, MXCT TTM earnings before interest, taxes, depreciation & amortization is -$42.03 million, with the most recent change of -$116.00 thousand (-0.28%) on September 30, 2024. Over the past year, it has increased by +$933.00 thousand (+2.17%). MXCT TTM EBITDA is now -1380.31% below its all-time high of -$2.84 million, reached on June 30, 2020.MXCT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MXCT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -78.9% | -0.9% | +2.2% |
| 3 y3 years | -343.8% | -122.7% | -70.4% |
| 5 y5 years | -457.8% | -122.7% | -70.4% |
MXCT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -165.6% | at low | -253.7% | at low | -195.2% | +4.8% |
| 5 y | 5-year | -343.8% | at low | -541.2% | at low | -1380.3% | +4.8% |
| alltime | all time | -6712.0% | at low | -541.2% | at low | -1380.3% | +4.8% |
MaxCyte EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.99 M(+19.3%) | -$42.03 M(+0.3%) |
| June 2024 | - | -$10.89 M(-2.5%) | -$41.92 M(-2.7%) |
| Mar 2024 | - | -$11.16 M(+59.6%) | -$43.08 M(-2.4%) |
| Dec 2023 | -$44.13 M(+78.9%) | -$6.99 M(-45.7%) | -$44.13 M(+2.7%) |
| Sept 2023 | - | -$12.87 M(+6.8%) | -$42.97 M(+15.9%) |
| June 2023 | - | -$12.05 M(-1.4%) | -$37.06 M(+11.6%) |
| Mar 2023 | - | -$12.22 M(+109.5%) | -$33.21 M(+34.6%) |
| Dec 2022 | -$24.66 M(+48.4%) | -$5.83 M(-16.3%) | -$24.66 M(+5.9%) |
| Sept 2022 | - | -$6.97 M(-14.9%) | -$23.29 M(+26.9%) |
| June 2022 | - | -$8.19 M(+123.1%) | -$18.35 M(+28.9%) |
| Mar 2022 | - | -$3.67 M(-17.6%) | -$14.24 M(-14.3%) |
| Dec 2021 | -$16.61 M | -$4.46 M(+120.1%) | -$16.61 M(+16.6%) |
| Sept 2021 | - | -$2.03 M(-50.4%) | -$14.25 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$4.08 M(-32.5%) | -$14.77 M(+9.2%) |
| Mar 2021 | - | -$6.05 M(+189.1%) | -$13.52 M(+80.9%) |
| Dec 2020 | -$9.94 M(-14.3%) | -$2.09 M(-17.8%) | -$7.48 M(+38.8%) |
| Sept 2020 | - | -$2.55 M(-10.4%) | -$5.38 M(+89.6%) |
| June 2020 | - | -$2.84 M | -$2.84 M |
| Dec 2019 | -$11.60 M(+46.6%) | - | - |
| Dec 2018 | -$7.91 M(-13.5%) | - | - |
| Dec 2017 | -$9.15 M(+251.6%) | - | - |
| Dec 2016 | -$2.60 M(+301.7%) | - | - |
| Dec 2015 | -$647.80 K(-45.3%) | - | - |
| Dec 2014 | -$1.18 M(+72.0%) | - | - |
| Dec 2013 | -$688.30 K(-62.0%) | - | - |
| Dec 2012 | -$1.81 M | - | - |
FAQ
- What is MaxCyte annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for MaxCyte?
- What is MaxCyte annual EBITDA year-on-year change?
- What is MaxCyte quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for MaxCyte?
- What is MaxCyte quarterly EBITDA year-on-year change?
- What is MaxCyte TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for MaxCyte?
- What is MaxCyte TTM EBITDA year-on-year change?
What is MaxCyte annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MXCT is -$44.13 M
What is the all time high annual EBITDA for MaxCyte?
MaxCyte all-time high annual earnings before interest, taxes, depreciation & amortization is -$647.80 K
What is MaxCyte annual EBITDA year-on-year change?
Over the past year, MXCT annual earnings before interest, taxes, depreciation & amortization has changed by -$19.46 M (-78.92%)
What is MaxCyte quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MXCT is -$12.99 M
What is the all time high quarterly EBITDA for MaxCyte?
MaxCyte all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2.03 M
What is MaxCyte quarterly EBITDA year-on-year change?
Over the past year, MXCT quarterly earnings before interest, taxes, depreciation & amortization has changed by -$116.00 K (-0.90%)
What is MaxCyte TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MXCT is -$42.03 M
What is the all time high TTM EBITDA for MaxCyte?
MaxCyte all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.84 M
What is MaxCyte TTM EBITDA year-on-year change?
Over the past year, MXCT TTM earnings before interest, taxes, depreciation & amortization has changed by +$933.00 K (+2.17%)